Intelligence with context.
Curated analysis of the forces shaping biopharma—from capital flows and FDA actions to scientific progress and competitive change. What changed, why it matters, and what to consider next.
For ambitious pharma & biotech leaders
The forces shaping your next decision don’t stop at the edge of your job description.
Meet BIOS—an executive intelligence membership combining curated industry insights, practical tools, and a selective community of peers. Built to help you see beyond your role and contribute beyond expectations.
Biopharma Intelligence and Opportunity Society
The BIOS idea / 72 seconds
More information isn’t enough. You need perspective—and people who help you put it to work.
The film introduces the membership vision. Join the waitlist to hear when applications open.
Sound on when you’re ready. Captions are included in the film.
Illustrative AI-generated professionals; not actual BIOS members.
You know your business. But do you see what’s shaping it?
Your calendar is full of decisions inside your company. Yet developments across the industry can change what those decisions mean.
More information isn’t enough. You need perspective, and people who help you put it to work.
Meet BIOS: the Biopharma Intelligence and Opportunity Society. An executive intelligence membership bringing together curated industry insights, practical tools, and a selective community of pharma and biotech peers.
Understand the connections beyond your function. Bring sharper questions to your team. Exchange experience with leaders who see the same challenges from different angles.
Not another report to read. A membership that helps you turn what you learn into what you contribute.
We share wisdom, not secrets, as we advance the industry for the patients we serve.
See beyond your role. Contribute beyond expectations. Your next contribution starts with a wider perspective. Apply for BIOS membership.
One membership. A wider field of view.
BIOS is being built around three connected advantages.
Curated analysis of the forces shaping biopharma—from capital flows and FDA actions to scientific progress and competitive change. What changed, why it matters, and what to consider next.
Practical reports, research resources, and insight tools designed to turn a wider view into better questions, stronger preparation, and more useful conversations at work.
A selective community across companies and functions. Exchange experience, explore challenges, and develop relationships through a shared commitment to meaningful contribution.
Our community standard
“We share wisdom, not secrets, as we advance the industry for the patients we serve.”
Public information. Professional experience. Respect for confidentiality.
For leaders who want to make a bigger difference
Designed for U.S.-based pharma and biotech leaders, generally director level and above, across functions.
With your permission, Rybbit measures visits, links, page interactions, and text copied on this site. It uses browser storage. Declining does not affect joining the waitlist. Privacy & Cookies